Muscle Stimulator Market

Executive Summary

Muscle Stimulator Market was valued at US $715.24 million in 2021 and is projected to grow at 4.37% CAGR over the forecast period to reach US $924.44 million by 2027. Muscle Stimulator Market represented US $58.63 million opportunity over 2019-2021 and estimated to create US $209.20 million opportunity in 2027 over 2021.

Muscle Stimulator from Consainsights analyses the Muscle Stimulator Market in the Life Sciences industry over the forecast period to 2027.

Muscle Stimulator research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Muscle Stimulator segmentation includes Product Type, Modality, Application and Geography.

Based on the Product Type, the Muscle Stimulator analysis covers Neuromuscular Electrical Stimulation, Functional Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Interferential, Other Product Types.

In Product Type segment, Neuromuscular Electrical Stimulation segment has highest cagr growth of 3.87%.

Based on the Modality, the Muscle Stimulator analysis covers Handheld, Portable.

In Modality segment, Handheld segment has highest cagr growth of 3.87%.

Based on the Application, the Muscle Stimulator analysis covers Neurological Disorders, Pain Management, Musculoskeletal Disorders, Others Applications.

In Application segment, Neurological Disorders segment has highest cagr growth of 3.87%.

Based on the region, the Muscle Stimulator analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Beurer GmbH, NeuroMetrix Inc., DJO Global, EMS Physio Ltd, Zynex Medical, BioMedical Life Systems, Omron Healthcare Inc., Liberate Medical, Innovative Health Solutions, Abbott Laboratories, RS Medical Inc., Mettler Electronics Corp., Tone-A-Matic, Zimmer MedizinSysteme GmbH and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product Type

Introduction

In 2021, Neuromuscular Electrical Stimulation segment has the highest revenue of US $318.14 million and is expected to grow at CAGR of 3.87% by 2027 Neuromuscular Electrical Stimulation segment has highest cagr growth of 3.87%.

Neuromuscular Electrical Stimulation

Neuromuscular Electrical Stimulation segment was valued at US $292.06 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $411.19 million by 2027. Neuromuscular Electrical Stimulation segment represented US $26.08 million opportunity over 2019-2021 and estimated to create US $93.05 million opportunity in 2027 over 2021.

Functional Electrical Stimulation

Functional Electrical Stimulation segment was valued at US $207.75 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $292.49 million by 2027. Functional Electrical Stimulation segment represented US $18.55 million opportunity over 2019-2021 and estimated to create US $66.19 million opportunity in 2027 over 2021.

Transcutaneous Electrical Nerve Stimulation

Transcutaneous Electrical Nerve Stimulation segment was valued at US $83.33 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $117.32 million by 2027. Transcutaneous Electrical Nerve Stimulation segment represented US $7.44 million opportunity over 2019-2021 and estimated to create US $26.55 million opportunity in 2027 over 2021.

Interferential

Interferential segment was valued at US $44.00 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $61.94 million by 2027. Interferential segment represented US $3.93 million opportunity over 2019-2021 and estimated to create US $14.02 million opportunity in 2027 over 2021.

Other Product Types

Other Product Types segment was valued at US $29.47 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $41.48 million by 2027. Other Product Types segment represented US $2.63 million opportunity over 2019-2021 and estimated to create US $9.39 million opportunity in 2027 over 2021.

Modality

Introduction

In 2021, Handheld segment has the highest revenue of US $452.07 million and is expected to grow at CAGR of 3.87% by 2027 Handheld segment has highest cagr growth of 3.87%.

Handheld

Handheld segment was valued at US $415.02 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $584.30 million by 2027. Handheld segment represented US $37.06 million opportunity over 2019-2021 and estimated to create US $132.22 million opportunity in 2027 over 2021.

Portable

Portable segment was valued at US $241.60 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $340.14 million by 2027. Portable segment represented US $21.57 million opportunity over 2019-2021 and estimated to create US $76.97 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Neurological Disorders segment has the highest revenue of US $331.49 million and is expected to grow at CAGR of 3.87% by 2027 Neurological Disorders segment has highest cagr growth of 3.87%.

Neurological Disorders

Neurological Disorders segment was valued at US $304.32 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $428.44 million by 2027. Neurological Disorders segment represented US $27.17 million opportunity over 2019-2021 and estimated to create US $96.95 million opportunity in 2027 over 2021.

Pain Management

Pain Management segment was valued at US $210.49 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $296.35 million by 2027. Pain Management segment represented US $18.79 million opportunity over 2019-2021 and estimated to create US $67.06 million opportunity in 2027 over 2021.

Musculoskeletal Disorders

Musculoskeletal Disorders segment was valued at US $92.87 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $130.75 million by 2027. Musculoskeletal Disorders segment represented US $8.29 million opportunity over 2019-2021 and estimated to create US $29.59 million opportunity in 2027 over 2021.

Others Applications

Others Applications segment was valued at US $48.93 million in 2019 and is projected to grow at 3.87% CAGR over the forecast period to reach US $68.89 million by 2027. Others Applications segment represented US $4.37 million opportunity over 2019-2021 and estimated to create US $15.59 million opportunity in 2027 over 2021.